Liver Transplantation: A Potential Cure for Hepatogenous Diabetes? Diabetes Care 2013;36:e97

Pallayová, Mária; Wilson, Violet; John, R.; Taheri, Shahrad

doi:10.2337/dc15-er01

Search citation statements

Order By: Relevance

Paper Sections

Select...

Metformin1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[68] Maria et al [62] reported that liver transplantation in HD patients, combined with treatment with tacrolimus, resulted in the cure of secondary diabetes while maintaining β-cell function. [69] Hence, liver transplantation can rapidly reverse the reduction of glucose tolerance associated with cirrhosis and serves as a necessary treatment option for HD when appropriate.…”

Section: Metforminmentioning

confidence: 99%

Advances in the treatment of hepatogenous diabetes: A review

Deng,

Li,

et al. 2023

Medicine

View full text Add to dashboard Cite

Hepatogenous diabetes (HD) is a glycogen metabolism disorder that arises as a consequence of chronic liver disease. The condition is frequently detected in patients diagnosed with cirrhosis, which is a result of advanced liver disease. The prognosis for patients with HD is generally poor, and they are at a heightened risk for serious complications such as gastrointestinal bleeding, primary peritonitis, and hepatic encephalopathy. Hepatogenous diabetes progression is often associated with cirrhosis progression, which leads to the development of liver cancer and increased patient mortality. Despite the prevalence and severity of HD, no systematic treatment strategy for clinical management of the condition has been proposed by any research or institutions to date. This paper conducts an extensive review of recent advancements in HD treatment in the quest for an effective treatment approach that may improve the overall prognosis of HD.

show abstract

Section: Metforminmentioning

confidence: 99%